Medical R&D firm Celsion has filed an FDA application to begin phase II trials of its investigational breast cancer treatment system, the company has announced.
Based on technology developed at the Massachusetts Institute of Technology for the U.S. "Star Wars" initiative, the system uses adaptive phased-array technology to focus microwaves directly on cancerous cells in order to ablate them with targeted heat, Columbia, MD-based Celsion said.
According to the firm's chairman and chief scientific officer Dr. Augustine Cheung, the system will enable patients who would otherwise undergo mastectomy to become candidates for lumpectomy. For patients with smaller tumors who would otherwise undergo lumpectomy, the treatment goal will be to ablate the tumors completely.
By AuntMinnie.com staff writers
November 10, 2000
Copyright © 2000 AuntMinnie.com
